Health in Burkina Faso
1,424 indicators covering health for Burkina Faso.
| Indicator | Latest | Year | 10-yr change | Rank |
|---|---|---|---|---|
| Probability of dying among adolescents ages 10-14 years, female | 2.4 per 1,000 | 2024 | down 51.0% | 50th |
| Probability of dying among children ages 5-9 years, male | 5.4 per 1,000 | 2024 | down 48.1% | 32nd |
| Probability of dying among children ages 5-9 years, female | 4.1 per 1,000 | 2024 | down 55.9% | 33rd |
| Probability of dying among adolescents ages 10-19 years | 9.6 per 1,000 | 2024 | down 25.0% | 39th |
| Women's share of population ages 15+ living with HIV | 63.7% | 2024 | up 9.0% | 24th |
| Deaths in armed conflicts by region, per square kilometre | 0.0233 units per square kilometre | 2023 | — | 4th |
| Deaths in armed conflicts by country, per square kilometre | 0.0233 units per square kilometre | 2023 | — | 4th |
| Maternal mortality ratio | 263.75 deaths per 100,000 live births | 2020 | down 26.2% | 33rd |
| Prevalence of HIV, male | 0.2% | 2024 | down 50.0% | 50th |
| Prevalence of HIV, female | 0.3% | 2024 | down 40.0% | 39th |
| Incidence of HIV, ages 15-49 | 0.18 per 1,000 uninfected population ages 15-49 | 2024 | down 10.0% | 76th |
| Incidence of HIV, all | 0.13 per 1,000 uninfected population | 2024 | down 23.5% | 68th |
| Prevalence of overweight | 21.7% | 2022 | up 46.6% | 187th |
| Prevalence of overweight, male | 17.4% | 2022 | up 30.9% | 185th |
| Prevalence of overweight, female | 25.8% | 2022 | up 58.5% | 186th |
| Immunization, HepB3 | 91.0% | 2024 | unchanged | 85th |
| HIV/AIDS deaths averted by antiretroviral therapy | 4,383 deaths | 2024 | up 3.3% | 41st |
| Live Births Surviving to Age 1 | 655.48 | 2100 | down 4.6% | 39th |
| Life expectancy at birth, projections | 71.61 years | 2100 | up 1.7% | 227th |
| Life expectancy at age 15 | 73.98 years | 2100 | up 1.2% | 226th |
| Incidence of HIV, ages 50+ | 0.1 per 1,000 uninfected population ages 50+ | 2024 | unchanged | 38th |
| Adults (ages 15+) and children (0-14 years) living with HIV | 93,000 | 2024 | down 7.0% | 47th |
| Incidence of HIV, ages 15-24 | 0.19 per 1,000 uninfected population ages 15-24 | 2024 | down 9.5% | 66th |
| Newborns protected against tetanus | 93.0% | 2024 | up 4.5% | 38th |
| Measles - number of reported cases | 4,099 | 2025 | up 4,040.4% | 23rd |
| Diphtheria - number of reported cases | 2 | 2025 | — | 50th |
| Total tetanus - number of reported cases | 199 | 2025 | — | 17th |
| Pertussis - number of reported cases | 14 | 2025 | — | 106th |
| Population ages 80 and above, male | 23,768 | 2025 | up 44.9% | 113th |
| Population ages 80 and above, female | 41,486 | 2025 | up 44.7% | 114th |
| Population ages 75-79, male | 40,905 | 2025 | up 25.3% | 101st |
| Population ages 75-79, female | 65,168 | 2025 | up 29.6% | 98th |
| Population ages 70-74, male | 74,400 | 2025 | up 18.2% | 99th |
| Population ages 70-74, female | 110,337 | 2025 | up 24.1% | 93rd |
| Population ages 65-69, male | 124,061 | 2025 | up 42.7% | 93rd |
| Population ages 65-69, female | 166,087 | 2025 | up 37.6% | 86th |
| Population ages 60-64, male | 179,300 | 2025 | up 51.8% | 86th |
| Population ages 60-64, female | 223,740 | 2025 | up 41.7% | 80th |
| Population ages 55-59, male | 241,462 | 2025 | up 44.0% | 82nd |
| Population ages 55-59, female | 284,222 | 2025 | up 38.0% | 78th |
| Population ages 50-54, male | 321,699 | 2025 | up 46.0% | 74th |
| Population ages 50-54, female | 355,977 | 2025 | up 38.8% | 71st |
| Population ages 45-49, male | 440,465 | 2025 | up 57.5% | 66th |
| Population ages 45-49, female | 463,499 | 2025 | up 48.3% | 64th |
| Population ages 40-44, male | 562,617 | 2025 | up 56.5% | 64th |
| Population ages 40-44, female | 578,048 | 2025 | up 51.1% | 64th |
| Population ages 35-39, male | 671,299 | 2025 | up 39.6% | 64th |
| Population ages 35-39, female | 683,525 | 2025 | up 38.8% | 62nd |
| Population ages 30-34, male | 784,867 | 2025 | up 29.4% | 60th |
| Population ages 30-34, female | 791,856 | 2025 | up 29.8% | 59th |
| Population ages 25-29, male | 944,159 | 2025 | up 31.1% | 59th |
| Population ages 25-29, female | 939,606 | 2025 | up 30.7% | 56th |
| Population ages 20-24, male | 1.15 million | 2025 | up 36.4% | 55th |
| Population ages 20-24, female | 1.13 million | 2025 | up 35.3% | 55th |
| Population ages 15-19, male | 1.41 million | 2025 | up 40.1% | 50th |
| Population ages 15-19, female | 1.37 million | 2025 | up 39.5% | 49th |
| Population ages 10-14, male | 1.62 million | 2025 | up 35.5% | 45th |
| Population ages 10-14, female | 1.57 million | 2025 | up 35.3% | 45th |
| Population ages 05-09, male | 1.69 million | 2025 | up 17.0% | 44th |
| Population ages 05-09, female | 1.64 million | 2025 | up 16.9% | 44th |